EE225 Exploring the Value of Country-Specific Cost-Effectiveness Models in Early Stages of Drug Development

Abstract

Authors

N. Ronquest K. Paret D.M. Mladsi L.J. Lee

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×